Ciprofloxacin eye drops recalled due to manufacturing temperature deviations
McKesson is recalling Ciprofloxacin Ophthalmic Solution 0.3% nationwide due to temperature deviations during manufacturing. The FDA classifies this as a Class II recall.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II FDA recall of a prescription medication with manufacturing deviations. While no illnesses or injuries have been reported, Class II recalls indicate potential for adverse health consequences. The actual harm remains theoretical without reported incidents.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Ciprofloxacin Ophthalmic Solution 0.3% distributed nationwide due to current Good Manufacturing Practice (cGMP) deviations involving temperature abuse during the manufacturing process.
The affected product is a 10 mL bottle of Ciprofloxacin Ophthalmic Solution 0.3%, a prescription antibiotic eye medication manufactured by Alcon Laboratories, Inc. (NDC 61314-0656-10). The product was distributed nationwide through McKesson Medical-Surgical.
The FDA has classified this as a Class II recall. McKesson is unable to identify specific lot numbers affected, but customers have been provided with distribution dates relevant to their shipments.
Patients who may have received this medication should consult with their pharmacy or prescriber to determine if their product is affected and whether a replacement prescription is needed.
The recalled product
- Product
- Ciprofloxacin Ophthalmic Solution 0.3%, 10 mL bottle, Rx only, Manufactured by: Alcon Laboratories, Inc., NDC 61314-0656-10
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Ophthalmic
- Hazard
- temperature-abuse
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01